Reaction
Delusional Disorder, Unspecified Type reporting signals
As of the last recalculation, Delusional Disorder, Unspecified Type appears in 738 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is ARIPIPRAZOLE ORAL (PRR 27.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Aripiprazole Oral | 38 | 27.3 | 27.3 |
| Aripiprazole Orally Disintegrating | 38 | 27.3 | 27.3 |
| Oxycodone Hydrochloride | 163 | 26.9 | 26.9 |
| Haloperidol | 20 | 23.8 | 23.9 |
| Haloperidol Lactate | 20 | 23.4 | 23.4 |
| Salmeterol Xinafoate | 6 | 19.8 | 19.8 |
| Olanzapine | 66 | 18.9 | 18.9 |
| Valproic Acid | 20 | 18.4 | 18.4 |
| Rivastigmine | 10 | 15.2 | 15.2 |
| Carbidopa And Levodopa | 24 | 14.7 | 14.7 |
| Clozapine | 56 | 13.5 | 13.5 |
| Rasagiline Mesylate | 5 | 12.7 | 12.8 |
| Paliperidone | 9 | 11.0 | 11.0 |
| Lurasidone Hydrochloride | 7 | 9.5 | 9.5 |
| Cariprazine | 3 | 9.1 | 9.1 |
| Droxidopa | 4 | 5.3 | 5.3 |